Role of Monoclonal Antibodies in the Treatment of Asthma
BACKGROUND: Patients with severe refractory asthma represent a small subset of the asthmatic population (between 5% and 10% of all patients) but are the greatest burden to the health care system. New treatment approaches developed to manage some of the phenotypes of severe refractory asthma have inc...
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2013-01-01
|
| Series: | Canadian Respiratory Journal |
| Acceso en liña: | http://dx.doi.org/10.1155/2013/183948 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|